Novel Therapy Used to Treat Severe, Disfiguring Disease 

Drug for arthritis used to treat patient with disfiguring sarcoidosis, a chronic disease affecting multiple organs

2 min read
Sarcoidosis is an inflammatory disease that affects multiple organs in the body.

Scientists have successfully treated a patient with disfiguring sarcoidosis, a chronic disease that can affect multiple organs, with a drug approved for rheumatoid arthritis.

Successful treatment of two other patients with similarly severe disease suggests an effective treatment for an incurable, sometimes life-threatening illness is within reach, according to the study published in the New England Journal of Medicine.

Sarcoidosis is an inflammatory disease that affects multiple organs in the body, said researchers from Yale University in the US.

While some sarcoidosis patients recover without treatment, others suffer damage to the lungs, heart, lymph nodes, skin, and other organs.

Current treatments, including steroids, are not reliably effective for the skin and can cause serious side effects.

Based on clues gleaned from prior studies, the team decided to try the arthritis medication tofacitinib.

The drug blocks a pathway known as Jak-STAT.

For several months, a 48-year-old female patient was treated with the drug, a twice-daily pill.

The researchers observed that her skin lesions nearly disappeared. They also performed RNA sequencing on biopsied skin from the patient before and during treatment.

According to Brett King, lead author of the study,

Before treatment, we were able to show that the Jak-STAT pathway is activated. During treatment, not only does her skin disease go away, but there is no activation of the pathway.

"We plan to evaluate the activation of the Jak-STAT pathway in the lung fluid and blood of over 200 patients with pulmonary and multiorgan sarcoidosis," said Nkiruka Emeagwali, co-author of the study.

These are big steps towards understanding a disease that has been a mystery for years, the researchers said.

The findings are being tested further by the team in a clinical trial. If confirmed, they could represent a breakthrough for sarcoidosis patients, King noted.

A frequently awful disease, which to date has no reliably effective therapy, may now be targeted with Jak inhibitors. 
Brett King

"We have a relatively safe medicine that works," King added.

(This story was auto-published from a syndicated feed. No part of the story has been edited by The Quint.)

(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)

We'll get through this! Meanwhile, here's all you need to know about the Coronavirus outbreak to keep yourself safe, informed, and updated.

Liked this story? We'll send you more. Subscribe to The Quint's newsletter and get selected stories delivered to your inbox every day. Click to get started.

The Quint is available on Telegram & WhatsApp too, click to join.

Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!